• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI Roundup
  • Pharma
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI Roundup
  • Pharma
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Cardiology

Aspirin use associated with reduction in cardiovascular events but increase in bleeding risk

byBrittany Hasty, MDandDaniel Fisher
January 23, 2019
in Cardiology, Chronic Disease, Emergency, Gastroenterology, Public Health
Reading Time: 2 mins read
0
Share on FacebookShare on Twitter

1. In this systematic review and meta-analysis, while aspirin use among patients without cardiovascular disease was associated with fewer adverse cardiovascular events, it was not associated with a reduction in all-cause mortality.

2. The use of aspirin in patients without cardiovascular disease was associated with increased risk of major bleeding.

Evidence Rating Level: 1 (Excellent)

Study Rundown: In patients with a history of cardiovascular disease, aspirin use has been associated with secondary prevention of stroke and myocardial infarction. However, the utility of aspirin for primary prevention in patients without a history of cardiovascular disease remains poorly understood. In this systematic review and meta-analysis including more than 160,000 patients, aspirin was associated with a reduction in the likelihood of adverse cardiovascular outcomes, such as cardiovascular mortality, nonfatal myocardial infarction, and nonfatal stroke, though there was no reduction in all-cause mortality. Aspirin was also found to significantly increase the risk of major bleeding events in this patient population.

While this study informs physicians regarding the use of aspirin as primary prevention of cardiovascular outcomes, it does not include a subgroup analysis to reveal any possible racial or gender differences in these outcomes. Previous studies have demonstrated that cardiovascular disease progression has both gender and racial differences, thus performing a subgroup analysis would allow physicians to better counsel their patients on the risks and benefits of aspirin use.

Click to read the study in JAMA

RELATED REPORTS

De-escalating dual antiplatelet therapy may lower major bleeding risk following drug-eluting stent implantation

#VisualAbstract: Apixaban is Superior to Aspirin for Stroke Prevention in People with Subclinical Atrial Fibrillation

Direct oral anticoagulants have similar bleeding risk compared with aspirin

Click to read an accompanying editorial in JAMA

Relevant Reading: Vital signs: prevalence of key cardiovascular disease risk factors for million hearts 2022 – United States, 2011-2016

In-Depth [systematic review and meta-analysis]: This study identified 1385 articles, of which, 21 met inclusion criteria and reported on 13 studies. These studies included 164,225 patients with a total of 1,050,511 patient-years of follow up. The primary cardiovascular outcome was a composite of cardiovascular mortality, nonfatal myocardial infarction, and nonfatal stroke (ischemic and hemorrhagic). The primary bleeding outcome was major bleeding of any kind as defined by the individual studies. Aspirin use was associated with a significant reduction in the composite cardiovascular outcome compared to no aspirin use (Hazard Ratio 0.89; CI95 0.84 to 0.95; number-needed-to-treat 265). This reduction in the composite cardiovascular outcome was present for patients who were both at low and high risk of cardiovascular events. The use of aspirin was not associated with a significant reduction in all-cause mortality (HR 0.94; CI95 0.88 to 1.01). Aspirin use was associated with an increased risk of major bleeding events compared to no aspirin use (HR 1.43; CI95 1.30 to 1.56; number-needed-to-harm 210). Aspirin use was associated with a 1.34 times higher likelihood of intracranial hemorrhage and a 1.56 times higher likelihood in major gastrointestinal bleeding.

Image: PD

©2019 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: aspirincardiovascular eventsmajor bleeding
Previous Post

Low free sugar diet reduces hepatic steatosis in nonalcoholic fatty liver disease in adolescent males

Next Post

Robust survival benefit seen in lupus nephritis patients receiving renal transplant

RelatedReports

Stent type may not be related to adverse cardiac events after surgery
Cardiology

De-escalating dual antiplatelet therapy may lower major bleeding risk following drug-eluting stent implantation

February 17, 2025
#VisualAbstract: Apixaban is Superior to Aspirin for Stroke Prevention in People with Subclinical Atrial Fibrillation
StudyGraphics

#VisualAbstract: Apixaban is Superior to Aspirin for Stroke Prevention in People with Subclinical Atrial Fibrillation

February 14, 2025
No significant increased risk of bladder cancer with pioglitazone use
Pharma

Direct oral anticoagulants have similar bleeding risk compared with aspirin

February 10, 2025
Drug-coated balloons are noninferior to drug-eluting stents for treatment of small vessel coronary artery disease
Cardiology

Ticagrelor monotherapy reduces bleeding risk compared to dual antiplatelet therapy for patients following coronary stenting

September 25, 2024
Next Post
Solitary kidney not associated with contrast-induced nephropathy

Robust survival benefit seen in lupus nephritis patients receiving renal transplant

The REACH trial: hydroxyurea safe and effective for sickle cell anemia in African children

Hematopoietic stem cell transplantation reduces transcranial doppler velocities in children with sickle cell anemia

Early language exposure is predictive of language skills and IQ in school-age children

Health care use stable after feeding tube placement in children with neurologic impairment

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Intravaginal conjugated oestrogen does not improve continuation rate of ring pessary use
  • Artificial intelligence based clinical decision systems are safe and effective for diabetes management
  • Epic Launchpad propels generative-AI into everyday hospital routines
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI Roundup
  • Pharma
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
No Result
View All Result

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.